IS8239A - Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur - Google Patents

Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur

Info

Publication number
IS8239A
IS8239A IS8239A IS8239A IS8239A IS 8239 A IS8239 A IS 8239A IS 8239 A IS8239 A IS 8239A IS 8239 A IS8239 A IS 8239A IS 8239 A IS8239 A IS 8239A
Authority
IS
Iceland
Prior art keywords
bicyclic
neuroprotective drugs
heptane derivative
produce neuroprotective
produce
Prior art date
Application number
IS8239A
Other languages
English (en)
Inventor
βn Gacs βlyi Istv
βbor Gigler G
βszlo G βbor H βrsing L
Lévay György
Moricz Krisztina
βria Simo Annam
βbor Szén βsi G
Original Assignee
Egis Gyogyszergy βr Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergy βr Rt. filed Critical Egis Gyogyszergy βr Rt.
Publication of IS8239A publication Critical patent/IS8239A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
IS8239A 2003-06-23 2006-01-18 Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur IS8239A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301906A HUP0301906A3 (en) 2003-06-23 2003-06-23 Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
PCT/HU2004/000062 WO2004112769A1 (en) 2003-06-23 2004-06-22 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IS8239A true IS8239A (is) 2006-01-18

Family

ID=90001689

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8239A IS8239A (is) 2003-06-23 2006-01-18 Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur

Country Status (23)

Country Link
US (1) US20060258750A1 (is)
EP (1) EP1660063A1 (is)
JP (1) JP2007516165A (is)
KR (1) KR20060023997A (is)
CN (1) CN1812778A (is)
AU (1) AU2004248982A1 (is)
BG (1) BG109414A (is)
BR (1) BRPI0411772A (is)
CA (1) CA2529254A1 (is)
CZ (1) CZ200631A3 (is)
EA (1) EA010868B1 (is)
HR (1) HRP20060023A2 (is)
HU (1) HUP0301906A3 (is)
IL (1) IL172408A0 (is)
IS (1) IS8239A (is)
MX (1) MXPA05014127A (is)
NO (1) NO20060277L (is)
PL (1) PL378630A1 (is)
RS (1) RS20050954A (is)
SK (1) SK50082006A3 (is)
UA (1) UA81052C2 (is)
WO (1) WO2004112769A1 (is)
ZA (1) ZA200510138B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
JP5528699B2 (ja) 2006-05-16 2014-06-25 武田薬品工業株式会社 縮合複素環化合物およびその用途
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
CZ301168B6 (cs) * 2008-10-09 2009-11-25 Ústav chemických procesu Akademie ved Ceské republiky Zpusob a zarízení pro izolaci kyseliny tereftalové
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Also Published As

Publication number Publication date
CZ200631A3 (cs) 2006-05-17
WO2004112769A1 (en) 2004-12-29
US20060258750A1 (en) 2006-11-16
EA010868B1 (ru) 2008-12-30
NO20060277L (no) 2006-01-19
HUP0301906D0 (en) 2003-08-28
HUP0301906A3 (en) 2006-03-28
BRPI0411772A (pt) 2006-08-08
KR20060023997A (ko) 2006-03-15
SK50082006A3 (sk) 2006-05-04
ZA200510138B (en) 2007-03-28
HRP20060023A2 (en) 2006-05-31
MXPA05014127A (es) 2006-02-24
CN1812778A (zh) 2006-08-02
BG109414A (bg) 2006-11-30
EP1660063A1 (en) 2006-05-31
AU2004248982A1 (en) 2004-12-29
RS20050954A (sr) 2007-08-03
PL378630A1 (pl) 2006-05-15
EA200600022A1 (ru) 2006-08-25
UA81052C2 (en) 2007-11-26
HUP0301906A2 (en) 2006-02-28
IL172408A0 (en) 2006-04-10
JP2007516165A (ja) 2007-06-21
CA2529254A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
IL163667A0 (en) Novel sustained release pharmaceutical compounds to preventabuse of controlled substances
MA26903A1 (fr) Production continue de granules pharmaceutiques
IL166058A0 (en) Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
EP1495141A4 (en) HIV THERAPEUTIC
NO20050970L (no) Fremstilling av et fermenteringsprodukt
CY2016031I1 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
IL163831A0 (en) Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing
EP1589917A4 (en) METHOD FOR THE ADMINISTRATION OF A DERMATOLOGICAL AGENT TO A PROBAND
NO20052914D0 (no) Terapeutiske forbindelser
EP1789075A4 (en) ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
AU2003261935A1 (en) Furan or thiophene derivative and medicinal use thereof
IS8913A (is) Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk
EP1664627A4 (en) FUNCTIONAL APPLICATION OF PHOTOCHROME CONNECTING MATERIALS TO PRODUCTS
SK4326U (sk) Farmaceutická kompozícia s predĺženým uvoľňovaním
EP1551426A4 (en) PROCESS FOR THE ADMINISTRATION OF FGF18
AU2003225432A1 (en) Delivery of a substance to a pre-determined site
IL172733A0 (en) Diphenylpyridine derivatives, preparation and therapeutic application thereof
AU2003296878A8 (en) Methods to administer epothilone d
PT1638943E (pt) Novos derivados de imidazoles, sua preparação e sua utilização como medicamento
EP1478356A4 (en) THERAPEUTIC COMPOUNDS
HUP0301906A2 (en) Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
NO20052177D0 (no) Anvendelse av galantamin og dets derivater for fremstilling av legemidler
AU2003901647A0 (en) Novel Condensed Furan Compounds and Pharmaceutical Use Thereof
GB0327742D0 (en) Novel uses of known drugs